Post-mastectomy radiotherapy reduces recurrence and mortality

Nature Reviews Clinical Oncology

Volumn 11, Issue 7, 2014, Pages 382-384

  Orecchia, Roberto ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOCOREGIONAL RECURRENCE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH NODE RATIO; LYMPH VESSEL METASTASIS; LYMPHEDEMA; META ANALYSIS (TOPIC); NOTE; POST MASTECTOMY RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; TUMOR VOLUME; ADJUVANT THERAPY; BREAST TUMOR; FEMALE; MASTECTOMY; PATHOLOGY; TUMOR RECURRENCE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL (TOPIC); DOSIMETRY; HIGH RISK POPULATION; OVERALL SURVIVAL; PATIENT CODING; PATIENT SELECTION; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK REDUCTION; SHORT SURVEY; SURVIVAL RATE;

BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT;

CYCLOPHOSPHAMIDE; FLUOROURACIL; KI 67 ANTIGEN; METHOTREXATE; TAMOXIFEN;

EID: 84903550332     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2014.95     Document Type: Note

References (10)

1. EBCTCG Early Breast Cancer Trialists Collaborative Group. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-Analysis of individual patient data for 8,135 women in 22 randomised trials. Lancet http://dx.doi.org/10.1016/S0140- 6736(14)60488-8.
2. Overgaard, M. et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b trial. N. Engl. J. Med. 337, 949-955 (1997).
3. Overgaard, M. et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group 82c randomised trial. Lancet 353, 1641-1648 (1999).
4. Recth, A. et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J. Clin. Oncol. 17, 1689-1700 (1999).
5. Katz, A. et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation. J. Clin. Oncol. 18, 2817-2827 (2000).
6. Taghian, A. et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from the five National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. J. Clin. Oncol. 22, 4247-4254 (2004).
7. Kim, S. I. et al. Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes. Br. J. Cancer 109, 1165-1171 (2013).
8. Shang, Y. P. et al. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status. Int. J. Radiat. Oncol. Biol. Phys. 77, 516-522 (2010).
9. Botteri, E. et al. Mastectomy without radiotherapy: Outcome analysis after 10 years of follow-up in a single institution. Breast Cancer Res. Treat. 134, 1221-1228 (2012).
10. Mukesh, M. B. et al. The Cambridge post-mastectomy radiotherapy (C-PMRT) index: A practical tool for patient selection. Radiother. Oncol. 110, 461-466 (2014).